結腸癌的病理生理學指的是導致結腸癌發展和進展的基本機制與過程.
結腸癌是一種從結腸或直腸開始的癌症,
癌症通常以多胞體的形式出現,
結腸癌的病理生理學涉及多種因素,
導致細胞無法控制生長及分裂.
基因突變是因為基因突變而造成的.
腸道炎症等疾病也可能增加患結腸癌的風險.
慢性炎症可能導致釋放促進細胞生長和分裂的化學物質,
必須以健康為基礎, 才能有效地預防癌症,
紅肉和加工肉類的飲食習慣,
其他因素如肥胖,吸煙及缺乏運動,
癌症從早期局限於結腸到晚期, 癌症已經擴散到身體其他部位.
癌細胞可以侵襲附近組織及器官,
結腸癌的治療通常包括手術,化療及射治療,
早期診斷與治療是改善結果的關鍵,
定期進行檢查, 如結腸鏡檢查,
PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html
RefinedWeb https://arxiv.org/abs/2306.01116
Vidal-Vanaclocha F: The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation. Cancer Microenviron. 2011, 4 (2): 163-80.
Yagi T, Kubota E, Koyama H, Tanaka T, Kataoka H, Imaeda K, Joh T: Glucagon promotes colon cancer cell growth via regulating AMPK and MAPK pathways. Oncotarget. 2018, 9 (12): 10650-10664.
Chen JK, Yaffe MB: Atlas Drugged. Cell. 2019, 177 (4): 803-805.
Sharma SH, Thulasingam S, Nagarajan S: Terpenoids as anti-colon cancer agents - A comprehensive review on its mechanistic perspectives. Eur J Pharmacol. 2017, 795 (): 169-178.
Keshk WA, Zineldeen DH, Wasfy RE, El-Khadrawy OH: Fatty acid synthase/oxidized low-density lipoprotein as metabolic oncogenes linking obesity to colon cancer via NF-kappa B in Egyptians. Med Oncol. 2014, 31 (10): 192.
Dongfeng D, An C, Shujia P, Jikai Y, Tao Y, Rui D, Kai T, Yafeng C, Jianguo L, Xilin D: Explanation of colon cancer pathophysiology through analyzing the disrupted homeostasis of bile acids. Afr Health Sci. 2014, 14 (4): 925-8.
Tammali R, Ramana KV, Srivastava SK: Aldose reductase regulates TNF-alpha-induced PGE2 production in human colon cancer cells. Cancer Lett. 2007, 252 (2): 299-306.
['提供醫療建議或專業服務.']
['提供給我們的資訊不應用於診斷或治療健康問題或疾病,']
['特別是數字內容不準確, 例如確診患有特定疾病的人數.']
['請隨時向您的醫生或其他合格的醫療人員諮詢您的病情. 請勿因為您在本網站上閱讀的內容而忽視專業醫療建議或延遲尋求. 如果您認為您可能有醫療緊急情況,請立即致電911或前往最近的急診室. 本網站或其使用並未建立醫師-病人關係. BioMedLib及其員工或本網站的任何貢獻者,都不會就此提供的信息或其使用作出任何明示或暗示的聲明.']
['該法案為那些認為網路上出現的內容侵犯了他們在美國版權法下的權利的版權所有者提供了補救. ']
['您 (或您的代理人) 可向我們發送通知, 要求移除內容或資料,或封鎖存取.']
['請見"聯絡方式"一節.']
['要求您的侵權聲明包含以下資訊: (1) 侵權聲明所涉及的著作的描述; (2) 侵權聲明所涉及的內容的描述及足以讓我們找到內容的資訊; (3) 您的聯絡方式,']
['(5) 您在作假宣誓的懲罰下簽署的聲明, 表示通知中的資訊是正確的,']
['且 (6) 版權所有者或授權代表其行動的人士的實物或電子簽名.']
['請填寫您的投訴內容.']
['請發送電子郵件給我們,']
The pathophysiology of colon cancer refers to the underlying mechanisms and processes that lead to the development and progression of colon cancer.
Colon cancer, also known as colorectal cancer, is a type of cancer that begins in the colon or rectum, which are parts of the large intestine.
It typically starts as a growth called a polyp, which can develop into cancer over time.
The pathophysiology of colon cancer involves several factors, including genetic mutations, inflammation, and environmental factors.
Genetic mutations can occur in the DNA of colon cells, leading to uncontrolled cell growth and division.
These mutations can be inherited or acquired, and they can affect various genes involved in cell growth, division, and repair.
Inflammation in the colon, which can be caused by conditions such as inflammatory bowel disease, can also increase the risk of colon cancer.
Chronic inflammation can lead to the release of chemicals that promote cell growth and division, potentially leading to the development of cancer.
Environmental factors, such as diet, lifestyle, and exposure to certain chemicals, can also contribute to the development of colon cancer.
A diet high in red and processed meats, for example, has been linked to an increased risk of colon cancer.
Other factors, such as obesity, smoking, and lack of physical activity, can also increase the risk.
Once colon cancer develops, it can progress through several stages, from early-stage cancer that is confined to the colon to more advanced stages where the cancer has spread to other parts of the body.
The cancer cells can invade nearby tissues and organs, and may also spread through the lymphatic system or bloodstream to distant sites, such as the liver or lungs.
Treatment for colon cancer typically involves a combination of surgery, chemotherapy, and radiation therapy, depending on the stage and location of the cancer.
Early detection and treatment are key to improving outcomes, as colon cancer is often curable when caught in its early stages.
Regular screening, such as colonoscopy, can help detect colon cancer at its earliest stages, when it is most treatable.
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['生物醫學圖書館使用自動化計算機 (機器學習算法) 來生成問答對.']
['開始於3500萬份的生物醫學出版物.']
['請見"參考資料"以及"聲明".']